The 5th Symposium on Diabetes Care - Agenda

5th Diabetes Symposium banner
The 5th Symposium on Diabetes Care

Symposium Focus Areas

1- Health Systems Transformation and Policy in Diabetes Care 2- Multidisciplinary and Team-based Models of Diabetes Care 3- Health Equity and Culturally Responsive Diabetes Care Across Diverse Populations
4- Early Detection, Risk Identification, and Timely Intervention in Prediabetes and Diabetes 5- Lifestyle Medicine and Primary Prevention 6- Emerging Therapeutics and Advances in Diabetes Care
7- Microvascular and Macrovascular Complications: Prevention, Screening, and Management 8- Diabetes in Pregnancy and the Postpartum Period: Maternal and Intergenerational Outcomes 9- Pediatric Obesity and the Prevention of Youth-Onset Type 2 Diabetes
10- Diabetes Technology and Data-Driven Care 11- Innovative Models of Diabetes Care Delivery  

 

Program Summary and Detailed Agenda

Date: Thursday November 12, 2026
Registration : 7:00 am – 8:00 am 

Scientific Program : 8:00 am – 2:30 pm [include breaks]

Venue: Dukhan Auditorium

 

Scientific Program

Time
Activity Description
Presenter Name and Affiliation
Learning Objectives

By the end of the session, participants will be able to:

7:00 am – 8:00 am Registration & Coffee Registration Team
8:00 am – 8:10 am Opening Ceremony & Welcome Remarks Prof. Rachid Benlamri
Vice President Academic, University of Doha for Science and Technology
 
8:10 am – 8:30 am

Focus Area (1): Health Systems Transformation and Policy in Diabetes Care

Keynote Presentation Title:

Health Systems Transformation and Policy in Diabetes Care in Qatar

Dr. Sheikh Mohamed Al Thani
Director of Non-Communicable Diseases Prevention Programs, Ministry of Public Health
  1. Outline the key priorities of Qatar's national diabetes strategy.
  2. Identify two policy actions that support diabetes prevention and care at the population level.
 

Q&A (5 minutes)

8:30 am – 8:50 am

Focus Area (2): Multidisciplinary Practice and Team-Based Models of Diabetes Care

Presentation Title:

From Education to Impact: Integrating Diabetes Patient Care into Health Professions Curricula

Prof. Shahrokh Esfandiari
Dean, College of Health Sciences, University of Doha for Science and Technology
  1. Identify core diabetes care competencies to incorporate into health professions curricula, including patient education, self-management support, and interprofessional collaboration.
  2. Describe practical strategies for teaching these competencies through case-based learning, simulation, and clinical experiences.
  3. Identify measures to evaluate the impact of curriculum integration on learner competence and readiness to deliver person-centered diabetes care.
 

Q&A (5 minutes)

8:50 am – 9:20 am

Focus Area (1): Health Systems Transformation and Policy in Diabetes Care [Saudi Arabia Vision 2030]

Keynote Presentation Title:

Diabetes Care in a Transforming Health System: Lessons from Saudi Vision 2030 and the Expanding Role of Pharmacists

Dr. Alaa Baglagel
Dean, College of Pharmacy
King Abdulaziz University
Jeddah, Saudi Arabia
  1. Describe the key health system and policy reforms under Saudi Vision 2030 that are reshaping how diabetes care is organized and delivered.
  2. Discuss how pharmacists can be integrated into team-based diabetes care models, and the policy, workforce and education enablers required to support this.
 

Q&A (5 minutes)

9:20 am – 9:40 am
Speakers Appreciation, Group Photo & Coffee Break
9:40 am – 10:00 am

Focus Area (2): Multidisciplinary Practice and Team-Based Models of Diabetes Care

Presentation Title:

Multidisciplinary Practice and Team-Based Models of Diabetes Care

Dr. Mohamed AlOtaibi
Senior Consultant Family Medicine – Primary Health Care Corporation
  1. Define multidisciplinary and team-based care, compare practical delivery models, recommendations and evidence.
  2. Discuss the implementation of team-based diabetes care models at Primary Healthcare Corporation.
 

Q&A (5 minutes)

10:00 am – 10:20 am

Focus Area (3): Health Equity and Culturally Responsive Diabetes Care Across Diverse Populations

Presentation Title:

Culture, Care, and Equity: Rethinking Diabetes Management for Diverse Populations.

Dr. Rayana Ahmed Bou Haka
Director of Qatar World Health Organization Office, State of Qatar
  1. Understand WHO's concepts of equity and responsive health systems with respect to diabetes prevention and control.
  2. Review the social, environmental and commercial determinants of health and their impact on diabetes.
  3. Consider a checklist for equitable and culturally appropriate diabetes prevention and control services.
  4. Examine implications for the health literacy of patients and communities, and for the competencies and skills of health care professionals.
 

Q&A (5 minutes)

10:20 am – 10:40 am

Focus Area (7): Microvascular and Macrovascular Complications: Prevention, Screening, and Management

Presentation Title:

Microvascular and Macrovascular Complications: Prevention, Screening, and Management

Dr. Haval Surchi
Consultant, Endocrinologist, Qatar Metabolic Institute, Hamad Medical Corporation
  1. Identify the major cardiovascular complications of diabetes and their key risk factors.
  2. List three evidence-based interventions that reduce cardiovascular risk in people with diabetes.
 

Q&A (5 minutes)

10:40 am – 11:00 am

Focus Area (7): Microvascular and Macrovascular Complications: Prevention, Screening, and Management

Presentation Title:

Diabetes-related Retinopathy

Prof. Rayaz Malik
Professor of Medicine, Weil Cornell Medical College-Qatar
Consultant Endocrinology, Hamad Medical Corporation
  1. Describe the stages of diabetes-related retinopathy and the recommended screening intervals.
  2. Identify two interventions that prevent or slow progression of retinopathy.
 

Q&A (5 minutes)

11:00 am – 12:00 pm
Lunch Break & Prayer
12:00 pm – 12:20 pm

Focus Area (9): Pediatric Obesity and the Prevention of Youth-Onset Type 2 Diabetes

Presentation Title:

From Risk to Prevention: Managing Pediatric Obesity to Reduce Youth-Onset Type 2 Diabetes

Dr. Hajar Dauleh
Pediatric Endocrinologist
Sidra Medicine
  1. Explain the link between childhood obesity and youth-onset type 2 diabetes.
  2. Identify two screening or prevention strategies for children and adolescents at risk.
 

Q&A (5 minutes)

12:20 pm – 12:40 pm

Focus Area (10): Diabetes Technology and Data-Driven Care

Presentation Title:

From Data to Decisions: Integrating CGM and Automated Insulin Delivery into Modern Diabetes Care.

Dr. Altayeb Abdalaziz
Senior Consultant Endocrinologist
The View Hospital
  1. Interpret three key CGM metrics, including time in range, to guide treatment decisions.
  2. Identify patients who are suitable candidates for automated insulin delivery systems.
 

Q&A (5 minutes)

12:40 pm – 1:00 pm

Focus Area (6): Emerging Therapeutics and Advances in Diabetes Care

Presentation Title:

GLP-1 Receptor Agonists and Beyond: Emerging Anti-obesity Medications

Dr. Amin Jayoussie
Senior Consultant, Endocrinology and Diabetes
Hamad Medical Corporation
Associate Professor, Weill Cornell Medical College-Qatar
  1. Compare the mechanisms and clinical benefits of GLP-1 receptor agonists and SGLT2 inhibitors.
  2. Select the appropriate agent for a patient based on cardiovascular, renal and weight considerations.
 

Q&A (5 minutes)

1:00 pm – 1:20 pm

Focus Area (8): Diabetes in Pregnancy and the Postpartum Period: Maternal and Intergenerational Outcomes

Presentation Title:

Diabetes in Pregnancy and the Postpartum Period: Maternal and Intergenerational Outcomes

Dr. Mohammad Bashir
Senior Consultant, Endocrinology and Diabetes
Hamad Medical Corporation
  1. Describe the maternal and intergenerational risks associated with diabetes in pregnancy.
  2. Outline the recommended postpartum screening and follow-up for women with gestational diabetes.
 

Q&A (5 minutes)

1:20 pm – 1:40 pm

Focus Area (11): Innovative Models of Diabetes Care Delivery

Presentation Title:

Identification of Innovative Targets for Prevention and Intervention of Type 1 Diabetes

Dr. Cong-Yi Wang
Scientific Director of the Diabetes Research Center at the Qatar Biomedical Research Institute
Hamad Bin Khalifa University (HBKU)
  1. Describe two emerging therapeutic targets for the prevention or treatment of type 1 diabetes.
  2. Explain how early identification of at-risk individuals supports preventive intervention.
 

Q&A (5 minutes)

1:40 pm – 2:25 pm

Focus Area (4): Early Detection and Action in Diabetes Care [International Diabetes Federation World Diabetes Day theme 2026]

Focus Area (5): Lifestyle Medicine and Primary Prevention

Panel Discussion: Early Action, Better Outcomes: Closing the Diabetes Diagnosis Gap

Moderator

Wisal Salih

Department Head, Pharmacy Technology, University of Doha for Science and Technology

Panelists

  1. Dr. Abdulla Al Hamaq
    Executive Director of Qatar Diabetes Association, State of Qatar
  2. Prof. Abdelhamid Kerkadi
    Department Head, Diabetes Care and Patient Education – College of Health Sciences – University of Doha for Science and Technology
  3. Prof. Khaled Alsuraimi
    Department Head, Healthcare Management – College of Business – University of Doha for Science and Technology
  4. Dr. Manal Musallam
    AED of Patient Education, Hamad Medical Corporation
  5. Amal Al Farsi
    Manager of Health and Wellness Education, Sidra Medicine
  1. Identify three barriers to early detection of prediabetes and diabetes in the community.
  2. Describe two lifestyle or education strategies that different professions can apply to prevent or delay type 2 diabetes.
 

Q&A (10 minutes)

2:25 pm – 2:30 pm Closing Remarks Prof. Shahrokh Esfandiari
Dean, College of Health Sciences, University of Doha for Science and Technology
 

Activity Code: API-01-P238

Target Audience: Physician, Dentist, Pharmacist, Allied Health Practitioner and Nurse

This activity is an Accredited group learning activity (Category 1) as defined by Ministry of Public Health’s Department of Healthcare Professions - Accreditation Section and is approved for a maximum of 5 hours

The Scientific Planning Committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.

The members of the Scientific Planning Committee do not have actual or potential conflict of interest or any financial interest in commercial products or services related to the subject of this CPD activity.